C6 NBD Galactosylceramide (d18:1/6:0) – 100 µg

Brand:
Cayman
CAS:
170212-26-7
Storage:
-20
UN-No:
Non-Hazardous - /

C6 NBD galactosylceramide is a biologically active derivative of galactosylceramide that is tagged with a fluorescent C6 nitrobenzoxadiazole (C6 NBD; Item No. 18871) group.{37105} C6 NBD galactosylceramide has been used to study intracellular localization and metabolism of galactosylceramide, a sphingolipid whose synthesis is disrupted in Krabbe disease due to a deficiency of galactosylceramide β-galactosidase.{37105,37104,37106} [Matreya, LLC. Catalog No. 1621]  

 

Out of stock

SKU: 22830 - Category:

Description

A fluorescently tagged sphingolipid; tagged with C6 NBD; used to study the intracellular localization and metabolism of galatosylceramide


Formal name: N-[(1S,2R,3E)-1-[(β-D-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-hexanamide

Synonyms:  C6 NBD Galactosylceramide|C6-NBD-GalCer|NBD Galactosylceramide (d18:1/6:0)|NBD GalCer(d18:1/6:0)|N-hexanoyl-NBD-Galactosylceramide

Molecular weight: 737.9

CAS: 170212-26-7

Purity: ≥98%

Formulation: A solid


Application|Enzyme Activity||Application|Fluorescence||Product Type|Biochemicals|Labeling & Detection|Enzyme Substrates||Product Type|Biochemicals|Labeling & Detection|Fluorescent Probes||Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Lipid Biochemistry|Sphingolipids